• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α细胞和β细胞在地中海贫血患者糖耐量受损中的作用。

Role of alpha and beta cells in the impaired glucose tolerance of thalassaemic subjects.

作者信息

Passariello N, Paolisso G, Sgambato S, D'Onofrio F

机构信息

Istituto di Medicina Generale, University of Naples, Italy.

出版信息

Diabete Metab. 1987 Jul-Aug;13(4):436-40.

PMID:3315764
Abstract

Fifty healthy and 12 thalassaemic subjects underwent both an oral glucose tolerance test (OGTT) and arginine test in order to investigate their alpha and beta cell activity. While basal plasma levels were similar in both group of subjects (82 +/- 4 vs 74 +/- 4 mg/dl, p = NS), following glucose intake impaired glucose tolerance was observed in thalassaemic subjects. These subjects showed impaired insulin secretion either in steady-state conditions or after glucose intake. When an arginine test was performed in thalassaemic subjects, impaired insulin secretion with concomitant exaggeration of glucagon response was also observed. In the thalassaemic subjects no statistically significant correlations were found between impaired insulin secretion and iron overload. It is suggested that in thalassaemic subjects beta-cell dysfunction and alpha cell overactivity may lead to the development of diabetes mellitus.

摘要

50名健康受试者和12名地中海贫血患者接受了口服葡萄糖耐量试验(OGTT)和精氨酸试验,以研究他们的α细胞和β细胞活性。两组受试者的基础血浆水平相似(82±4 vs 74±4mg/dl,p=无显著性差异),但地中海贫血患者在摄入葡萄糖后出现糖耐量受损。这些受试者在稳态条件下或摄入葡萄糖后胰岛素分泌均受损。当对地中海贫血患者进行精氨酸试验时,也观察到胰岛素分泌受损,同时胰高血糖素反应增强。在地中海贫血患者中,胰岛素分泌受损与铁过载之间未发现统计学上的显著相关性。提示在地中海贫血患者中,β细胞功能障碍和α细胞活性过高可能导致糖尿病的发生。

相似文献

1
Role of alpha and beta cells in the impaired glucose tolerance of thalassaemic subjects.α细胞和β细胞在地中海贫血患者糖耐量受损中的作用。
Diabete Metab. 1987 Jul-Aug;13(4):436-40.
2
Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.肠促胰岛素对糖耐量正常或受损受试者β细胞功能的影响。
Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1144-50. doi: 10.1152/ajpendo.00571.2005. Epub 2006 Feb 14.
3
Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.胰高血糖素反应对糖耐量受损男性和2型糖尿病患者餐后高血糖的影响。
Metabolism. 2005 Sep;54(9):1168-73. doi: 10.1016/j.metabol.2005.03.024.
4
Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.在糖耐量正常或空腹血糖受损的受试者中,口服葡萄糖负荷后血清高分子量脂联素会突然下降,但糖耐量受损或糖尿病患者不会出现这种情况。
Metabolism. 2009 Oct;58(10):1470-6. doi: 10.1016/j.metabol.2009.04.042. Epub 2009 Jul 9.
5
Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.重型β地中海贫血因铁过载导致患糖尿病风险增加。
Helv Paediatr Acta. 1979;34(3):197-207.
6
Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon.反应性低血糖发病机制的研究:胰岛素与胰高血糖素的作用
Horm Metab Res. 1976;Suppl 6:91-8.
7
Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance.降低餐后高血糖对糖耐量受损老年人胰岛素分泌的影响。
Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E906-11. doi: 10.1152/ajpendo.00156.2004. Epub 2004 Jun 22.
8
Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.接受强化输血治疗的重型地中海贫血患者的胰岛素抵抗和高胰岛素血症。
N Engl J Med. 1988 Mar 31;318(13):809-14. doi: 10.1056/NEJM198803313181303.
9
Minor physiological relevance of oral glucose tolerance test.口服葡萄糖耐量试验的生理相关性较小。
Diabete Metab. 1982 Sep;8(3):203-7.
10
Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.罗格列酮改善糖耐量受损的非肥胖受试者的胰岛素敏感性:脂联素和C反应蛋白的作用。
Metabolism. 2006 Apr;55(4):439-44. doi: 10.1016/j.metabol.2005.10.004.